Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Gastrointestinal 314Thoracic 233Breast 111Gynecologic 80Head & Neck 77Lymphoid 66Other hematologic neoplasm 55CNS 44Genitourinary 36Sarcoma 32Other solid neoplasm 30Tumor-Agnostic 23Dermatologic 17Plasma cell 10Myeloid 7Classical hematology 6Other 3Endocrine 2Other neoplasm 1NET 1

Conditions

Sarcoma 1Neoplasms 1Neoplasm Metastasis 1Carcinoma, Neuroendocrine 1Advanced Pancreatic Neuroendocrine Tumor 1Adrenocortical Carcinoma 1

Interventions

Everolimus 59lutetium Lu 177 dotatate 46Magnetic Resonance Spectroscopy 33pembrolizumab 31Temozolomide 31Cisplatin 29Nivolumab 26Octreotide 24lanreotide 23cabozantinib 22pasireotide 21gallium Ga 68 dotatate 21lenvatinib 20Etoposide 19Specimen Handling 18Paclitaxel 18Carboplatin 18Capecitabine 18Sunitinib 17Bevacizumab 16trametinib 15dabrafenib 15Doxorubicin 143-Iodobenzylguanidine 14surufatinib 13Sorafenib 13Ipilimumab 13Thyrotropin Alfa 12Injections 12Positron Emission Tomography Computed Tomography 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Drug Therapy × Endocrine × Clear all
NCT06333314 2025-12-02

Pan-MSI-ACSE

UNICANCER

Phase 2 Recruiting
120 enrolled
EndocrineSarcoma

Neoplasm Metastasis, Neoplasms, Sarcoma, Adrenocortical Carcinoma, Carcinoma, Neuroendocrine

NCT06246630 2024-05-16

In Vitro Organoid Drug Sensitivity-Guided Treatment for Advanced Pancreatic Neuroendocrine Tumor

Ruijin Hospital

Phase NA Recruiting
20 enrolled
EndocrineGastrointestinalNET

Advanced Pancreatic Neuroendocrine Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡